887 related articles for article (PubMed ID: 29337182)
1. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.
Seino T; Kawasaki S; Shimokawa M; Tamagawa H; Toshimitsu K; Fujii M; Ohta Y; Matano M; Nanki K; Kawasaki K; Takahashi S; Sugimoto S; Iwasaki E; Takagi J; Itoi T; Kitago M; Kitagawa Y; Kanai T; Sato T
Cell Stem Cell; 2018 Mar; 22(3):454-467.e6. PubMed ID: 29337182
[TBL] [Abstract][Full Text] [Related]
2. Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis.
Nanki K; Toshimitsu K; Takano A; Fujii M; Shimokawa M; Ohta Y; Matano M; Seino T; Nishikori S; Ishikawa K; Kawasaki K; Togasaki K; Takahashi S; Sukawa Y; Ishida H; Sugimoto S; Kawakubo H; Kim J; Kitagawa Y; Sekine S; Koo BK; Kanai T; Sato T
Cell; 2018 Aug; 174(4):856-869.e17. PubMed ID: 30096312
[TBL] [Abstract][Full Text] [Related]
3. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB
Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841
[TBL] [Abstract][Full Text] [Related]
4. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
[TBL] [Abstract][Full Text] [Related]
5. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T
Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618
[TBL] [Abstract][Full Text] [Related]
6. EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of
Patil S; Steuber B; Kopp W; Kari V; Urbach L; Wang X; Küffer S; Bohnenberger H; Spyropoulou D; Zhang Z; Versemann L; Bösherz MS; Brunner M; Gaedcke J; Ströbel P; Zhang JS; Neesse A; Ellenrieder V; Singh SK; Johnsen SA; Hessmann E
Cancer Res; 2020 Nov; 80(21):4620-4632. PubMed ID: 32907838
[TBL] [Abstract][Full Text] [Related]
7. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.
Liu X; Cheng Y; Abraham JM; Wang Z; Wang Z; Ke X; Yan R; Shin EJ; Ngamruengphong S; Khashab MA; Zhang G; McNamara G; Ewald AJ; Lin D; Liu Z; Meltzer SJ
Cancer Lett; 2018 Nov; 436():109-118. PubMed ID: 30144514
[TBL] [Abstract][Full Text] [Related]
8. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
9. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1.
Zhong Y; Wang Z; Fu B; Pan F; Yachida S; Dhara M; Albesiano E; Li L; Naito Y; Vilardell F; Cummings C; Martinelli P; Li A; Yonescu R; Ma Q; Griffin CA; Real FX; Iacobuzio-Donahue CA
PLoS One; 2011; 6(7):e22129. PubMed ID: 21811562
[TBL] [Abstract][Full Text] [Related]
10. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
11. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.
Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX
Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178
[TBL] [Abstract][Full Text] [Related]
12. Sequential cancer mutations in cultured human intestinal stem cells.
Drost J; van Jaarsveld RH; Ponsioen B; Zimberlin C; van Boxtel R; Buijs A; Sachs N; Overmeer RM; Offerhaus GJ; Begthel H; Korving J; van de Wetering M; Schwank G; Logtenberg M; Cuppen E; Snippert HJ; Medema JP; Kops GJ; Clevers H
Nature; 2015 May; 521(7550):43-7. PubMed ID: 25924068
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.
Steinhart Z; Pavlovic Z; Chandrashekhar M; Hart T; Wang X; Zhang X; Robitaille M; Brown KR; Jaksani S; Overmeer R; Boj SF; Adams J; Pan J; Clevers H; Sidhu S; Moffat J; Angers S
Nat Med; 2017 Jan; 23(1):60-68. PubMed ID: 27869803
[TBL] [Abstract][Full Text] [Related]
14. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.
Fujii M; Shimokawa M; Date S; Takano A; Matano M; Nanki K; Ohta Y; Toshimitsu K; Nakazato Y; Kawasaki K; Uraoka T; Watanabe T; Kanai T; Sato T
Cell Stem Cell; 2016 Jun; 18(6):827-838. PubMed ID: 27212702
[TBL] [Abstract][Full Text] [Related]
15. Modeling Human Digestive Diseases With CRISPR-Cas9-Modified Organoids.
Fujii M; Clevers H; Sato T
Gastroenterology; 2019 Feb; 156(3):562-576. PubMed ID: 30476497
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer.
Chen K; Ma Y; Zhong X; Lan J; Long D; Tian X; Yang Y; Yang Y
Cancer Lett; 2024 Feb; 582():216586. PubMed ID: 38081505
[TBL] [Abstract][Full Text] [Related]
17. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
[TBL] [Abstract][Full Text] [Related]
18. A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer.
Kloesch B; Ionasz V; Paliwal S; Hruschka N; Martinez de Villarreal J; Öllinger R; Mueller S; Dienes HP; Schindl M; Gruber ES; Stift J; Herndler-Brandstetter D; Lomberk GA; Seidler B; Saur D; Rad R; Urrutia RA; Real FX; Martinelli P
Gut; 2022 Apr; 71(4):766-777. PubMed ID: 33846140
[TBL] [Abstract][Full Text] [Related]
19. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptome analysis identifies distinct cell types and niche signaling in a primary gastric organoid model.
Chen J; Lau BT; Andor N; Grimes SM; Handy C; Wood-Bouwens C; Ji HP
Sci Rep; 2019 Mar; 9(1):4536. PubMed ID: 30872643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
